• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对医疗补助受助人实施更严格处方限制的影响。对成本、治疗及自付费用的影响。

The impact of implementing a more restrictive prescription limit on Medicaid recipients. Effects on cost, therapy, and out-of-pocket expenditures.

作者信息

Martin B C, McMillan J A

机构信息

Department of Pharmacy Care Administration, College of Pharmacy, University of Georgia, Athens 30602, USA.

出版信息

Med Care. 1996 Jul;34(7):686-701. doi: 10.1097/00005650-199607000-00003.

DOI:10.1097/00005650-199607000-00003
PMID:8676607
Abstract

On November 1, 1991, the Georgia Department of Medical Assistance reduced the maximum number of monthly reimbursable prescriptions from six to five. This policy change provided a natural experiment to investigate the recipient responses to a decrease in an existing prescription limit. The research design was a quasiexperimental, retrospective, 12-month interrupted time-series analysis of a cohort. The cohort consisted of 743 ambulatory recipients who were high prescription users. Complete Medicaid claims data were obtained, in addition to pharmacy-generated computer profiles for all cohort recipients to determine Medicaid and out-of-pocket prescriptions expenditures. Interrupted time-series analyses were performed to model the effect of the five-prescription limit on total, Medicaid-reimbursed, out-of-pocket, and prescription use across eight therapeutic categories. After the implementation of the five-prescription limit, total prescription use fell 6.6%, prescriptions reimbursed by Medicaid fell 9.9%, and prescriptions paid for out-of-pocket increased 9.7%. Abrupt, permanent decreases were observed for cardiovascular, miscellaneous, pulmonary, and palliative therapeutic drug categories (alpha = 0.05), whereas gastrointestinal, chemotherapy, hormone (insulin), and central nervous system prescription use remained constant. The implementation of a more restrictive prescription limit alters prescription regimens potentially predisposing elderly Medicaid recipients to clinical consequences. Further examination of the health outcomes of these recipients is necessary.

摘要

1991年11月1日,佐治亚州医疗救助部门将每月可报销处方的最大数量从6张减至5张。这一政策变化提供了一个自然实验,用以调查受助者对现有处方限额降低的反应。研究设计为对一个队列进行的准实验性、回顾性、为期12个月的中断时间序列分析。该队列由743名高处方量的门诊受助者组成。除了获取所有队列受助者药房生成的计算机资料以确定医疗补助和自付处方费用外,还获得了完整的医疗补助理赔数据。进行了中断时间序列分析,以模拟五项处方限额对八个治疗类别的总处方量、医疗补助报销处方量、自付处方量和处方使用情况的影响。五项处方限额实施后,总处方使用量下降了6.6%,医疗补助报销的处方量下降了9.9%,自付处方量增加了9.7%。心血管、杂类、肺部和姑息治疗药物类别出现了突然、永久性的下降(α = 0.05),而胃肠道、化疗、激素(胰岛素)和中枢神经系统的处方使用量保持不变。实施更严格的处方限额会改变处方用药方案,这可能使老年医疗补助受助者面临临床后果。有必要对这些受助者的健康结果作进一步研究。

相似文献

1
The impact of implementing a more restrictive prescription limit on Medicaid recipients. Effects on cost, therapy, and out-of-pocket expenditures.对医疗补助受助人实施更严格处方限制的影响。对成本、治疗及自付费用的影响。
Med Care. 1996 Jul;34(7):686-701. doi: 10.1097/00005650-199607000-00003.
2
Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity.医疗补助计划下处方药的支付限制。对治疗、成本和公平性的影响。
N Engl J Med. 1987 Aug 27;317(9):550-6. doi: 10.1056/NEJM198708273170906.
3
Trends in prescription drug expenditures by Medicaid enrollees.医疗补助计划参保者的处方药支出趋势。
Med Care. 2006 May;44(5 Suppl):I27-35. doi: 10.1097/01.mlr.0000208132.36055.84.
4
Prescription drugs: issues of cost, coverage, and quality.处方药:成本、保险范围及质量问题。
EBRI Issue Brief. 1999 Apr(208):1-21.
5
Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients.年度美元限额或“上限”对医疗保险患者处方药福利的影响。
JAMA. 2003 Jul 9;290(2):222-7. doi: 10.1001/jama.290.2.222.
6
Medicaid prescription limits: policy trends and comparative impact on utilization.医疗补助计划的处方限制:政策趋势及其对使用情况的比较影响
BMC Health Serv Res. 2016 Jan 15;16:15. doi: 10.1186/s12913-016-1258-0.
7
Elimination of over-the-counter medication coverage in the Oregon Medicaid population: the impact on program costs and drug use.俄勒冈医疗补助计划人群中取消非处方药保险:对计划成本和药物使用的影响。
Med Care. 1998 Aug;36(8):1283-94. doi: 10.1097/00005650-199808000-00015.
8
Impact of Medicare Part D on Medicare-Medicaid dual-eligible beneficiaries' prescription utilization and expenditures.医疗保险处方药部分对医疗保险-医疗补助双重资格受益人的处方使用和支出的影响。
Health Serv Res. 2010 Feb;45(1):133-51. doi: 10.1111/j.1475-6773.2009.01065.x. Epub 2009 Dec 4.
9
The impact of Medicare Part D on prescription drug use by the elderly.医疗保险D部分对老年人处方药使用的影响。
Health Aff (Millwood). 2007 Nov-Dec;26(6):1735-44. doi: 10.1377/hlthaff.26.6.1735.
10
Medicaid prescription drug utilization and expenditures following Part D.医疗补助计划(Medicaid)在D部分之后的处方药使用情况及支出
J Health Care Poor Underserved. 2010 May;21(2):715-28. doi: 10.1353/hpu.0.0278.

引用本文的文献

1
Rural and urban differences in quality of dementia care of persons with dementia and caregivers across all domains: a systematic review.农村和城市在痴呆症患者和护理人员所有领域的痴呆症护理质量方面的差异:系统评价。
BMC Health Serv Res. 2023 Jan 31;23(1):102. doi: 10.1186/s12913-023-09100-8.
2
Perception of quality of health delivery and health insurance subscription in Ghana.加纳对医疗服务质量和医疗保险参保情况的认知
BMC Health Serv Res. 2016 Jul 29;16:317. doi: 10.1186/s12913-016-1602-4.
3
Medicaid prescription limits: policy trends and comparative impact on utilization.
医疗补助计划的处方限制:政策趋势及其对使用情况的比较影响
BMC Health Serv Res. 2016 Jan 15;16:15. doi: 10.1186/s12913-016-1258-0.
4
Pharmaceutical policies: effects of cap and co-payment on rational use of medicines.药品政策:封顶价和共付额对合理用药的影响。
Cochrane Database Syst Rev. 2015 May 8;2015(5):CD007017. doi: 10.1002/14651858.CD007017.pub2.
5
Changes in drug coverage generosity and untreated serious mental illness: transitioning from Medicaid to Medicare Part D.药物覆盖范围慷慨程度的变化与未经治疗的严重精神疾病:从医疗补助计划过渡到医疗保险部分 D。
JAMA Psychiatry. 2015 Feb;72(2):179-88. doi: 10.1001/jamapsychiatry.2014.1259.
6
Adherence to anti-diabetic drugs among patients with Type 2 diabetes mellitus at Muhimbili National Hospital, Dar es Salaam, Tanzania- A cross-sectional study.坦桑尼亚达累斯萨拉姆穆希姆比利国家医院2型糖尿病患者对抗糖尿病药物的依从性——一项横断面研究。
Pan Afr Med J. 2014 Apr 7;17:252. doi: 10.11604/pamj.2014.17.252.2972. eCollection 2014.
7
Changes in use of lipid-lowering medications among black and white dual enrollees with diabetes transitioning from Medicaid to Medicare Part D drug coverage.患有糖尿病的黑人和白人双重参保者从医疗补助计划过渡到医疗保险D部分药物保险期间降脂药物使用情况的变化。
Med Care. 2014 Aug;52(8):695-703. doi: 10.1097/MLR.0000000000000159.
8
Hospitalizations and deaths among adults with cardiovascular disease who underuse medications because of cost: a longitudinal analysis.因费用问题而未使用药物的心血管疾病成年患者的住院和死亡情况:一项纵向分析。
Med Care. 2010 Feb;48(2):87-94. doi: 10.1097/MLR.0b013e3181c12e53.
9
Cost sharing and the initiation of drug therapy for the chronically ill.成本分担与慢性病药物治疗的启动
Arch Intern Med. 2009 Apr 27;169(8):740-8; discussion 748-9. doi: 10.1001/archinternmed.2009.62.
10
Turning 65 in Ontario: the impact of public drug benefit coverage on hospitalizations for acute and chronic disease.安大略省年满65岁:公共药物福利覆盖对急慢性疾病住院治疗的影响。
Healthc Policy. 2006 Mar;1(3):87-98.